- Home
- CRBP vs HOFT Comparison
CRBP vs HOFT Comparison
Compare CRBP & HOFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- HOFT
- Stock Information
- Founded
- CRBP 2009
- HOFT 1924
- Country
- CRBP United States
- HOFT United States
- Employees
- CRBP N/A
- HOFT N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- HOFT Home Furnishings
- Sector
- CRBP Health Care
- HOFT Consumer Discretionary
- Exchange
- CRBP Nasdaq
- HOFT Nasdaq
- Market Cap
- CRBP 114.8M
- HOFT 105.4M
- IPO Year
- CRBP N/A
- HOFT 1999
- Fundamental
- Price
- CRBP $9.50
- HOFT $10.34
- Analyst Decision
- CRBP Strong Buy
- HOFT
- Analyst Count
- CRBP 10
- HOFT 0
- Target Price
- CRBP $53.22
- HOFT N/A
- AVG Volume (30 Days)
- CRBP 91.8K
- HOFT 39.4K
- Earning Date
- CRBP 11-06-2025
- HOFT 09-11-2025
- Dividend Yield
- CRBP N/A
- HOFT 8.90%
- EPS Growth
- CRBP N/A
- HOFT N/A
- EPS
- CRBP N/A
- HOFT N/A
- Revenue
- CRBP N/A
- HOFT $376,278,000.00
- Revenue This Year
- CRBP N/A
- HOFT N/A
- Revenue Next Year
- CRBP $220.04
- HOFT $15.15
- P/E Ratio
- CRBP N/A
- HOFT N/A
- Revenue Growth
- CRBP N/A
- HOFT N/A
- 52 Week Low
- CRBP $4.64
- HOFT $7.34
- 52 Week High
- CRBP $56.93
- HOFT $19.79
- Technical
- Relative Strength Index (RSI)
- CRBP 49.85
- HOFT 49.80
- Support Level
- CRBP $9.42
- HOFT $9.21
- Resistance Level
- CRBP $9.73
- HOFT $11.11
- Average True Range (ATR)
- CRBP 0.51
- HOFT 0.47
- MACD
- CRBP -0.08
- HOFT 0.06
- Stochastic Oscillator
- CRBP 15.33
- HOFT 59.47
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.